EHRA Premium Access

Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different benefit in case of acute coronary syndrome?

Topic: Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation

Congress Presentation

About the speaker

Doctor Arnaud Bisson

CHU de Tours, Tours (France)
0 follower

6 more presentations in this session

Incidence of atrial arrhythmia and uptake of anticoagulation in stroke and non-stroke populations according to arrhythmia burden; a 7-year experience.

Speaker: Doctor P. Chousou (Cambridge, GB)


Relation of Nonsteroidal Anti-Inflammatory Drugs and Time in Therapeutic Range in Bleeding Risk in Atrial Fibrillation: the SPORTIF Trials

Speaker: Doctor M. Proietti (Milan, IT)


Incidence and predictors of left atrial appendage thrombus in patients treated with direct oral anticoagulants versus warfarin for non-valvular atrial fibrillation

Speaker: Doctor K. Minami (Utsunomiya, JP)


Left atrial stunning as a predictor of atrial fibrillation occurrence after cryptogenic stroke

Speaker: Doctor J. Farinha (Setubal, PT)


Indications for and outcome in patients undergoing left atrial appendage closure - Results of the Austrian LAAC Registry

Speaker: Mr D. Zweiker (Vienna, AT)


Access the full session

Managing the thromboembolic risk in atrial fibrillation

Speakers: Doctor A. Bisson, Doctor P. Chousou, Doctor M. Proietti, Doctor K. Minami, Doctor J. Farinha...

About the event


EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb